Foundations of Psychedelic Assisted Therapy

This course offers an in-depth introduction to psychedelic compounds most
commonly utilized in psychedelic-assisted therapy, along with the history, theory, stakeholders, and social issues prominent in the field. Both psilocybin and MDMA have received a “Breakthrough Therapy” designation from the FDA. Additionally, the prevalence of ketamine-assisted psychotherapy practices and increased access to these medicines overall make it important for the next generation of clinicians to be familiar with psychedelic-assisted therapy (PAT) practices.